{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:28:33Z","timestamp":1649057313280},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.2169\/internalmedicine.4584-20","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T22:06:03Z","timestamp":1594073163000},"page":"2505-2509","source":"Crossref","is-referenced-by-count":0,"title":["Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma"],"prefix":"10.2169","volume":"59","author":[{"given":"Suguru","family":"Hirose","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Yamaura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Mizui","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nagase","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Hattori","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Ishige","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichinosuke","family":"Hyodo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Mizokami","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"},{"name":"Endoscopic Center, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Bhosale P, Shah A, Wei W, et al. Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur Radiol 23: 400-407, 2013."},{"key":"2","unstructured":"2. Kirshbom PM, Kherani AR, Onaitis MW, Feldman JM, Tyler DS. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids. Surgery 124: 1063-1070, 1998."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Morihiro T, Aoki H, Kanaya N, et al. Multiple liver metastases of a neuroendocrine carcinoma of unknown origin. Jpn J Gastroenterol Surg 48: 94-101, 2015 (in Japanese, Abstract in English).","DOI":"10.5833\/jjgs.2014.0022"},{"key":"4","unstructured":"4. Klimstra D, Kloppel G, La Rosa S, Rindi G. WHO classification of tumours. In: 5th Edition Digestive System Tumours. International Agency for Research on Cancer, Lyon, 2019: 16-21."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Pavel M, O&apos;Toole D, Costa F, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology 103: 172-185, 2016.","DOI":"10.1159\/000443167"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Nishikura K, Watanabe H, Iwafuchi M, Fujiwara T, Kojima K, Ajioka Y. Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration. Gastric Cancer 6: 203-209, 2003.","DOI":"10.1007\/s10120-003-0249-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shia J, Tang LH, Weiser MR, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 32: 719-731, 2008.","DOI":"10.1097\/PAS.0b013e318159371c"},{"key":"8","unstructured":"8. Brenner B, Tang LH, Shia J, Klimstra DS, Kelsen DP. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin Oncol 34: 43-50, 2007."},{"key":"9","unstructured":"9. Sterlacci W, Fiegl M, Hilbe W, Auberger J, Mikuz G, Tzankov A. Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases. Virchows Arch 455: 125-132, 2009."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Riquet M, Badoual Cc, Barthes FolP, Dujon A, Danel C. Metastatic thoracic lymph node carcinoma with unknown primary site. The Annals of thoracic surgery 75: 244-249, 2003.","DOI":"10.1016\/S0003-4975(02)04119-X"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Becht E, Giraldo NA, Germain C, et al. Immune contexture, immiunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers. Adv Immunol 130: 95-190, 2016.","DOI":"10.1016\/bs.ai.2015.12.002"},{"key":"12","unstructured":"12. Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol 24: 152-160, 2013."},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Moertel CG, Kvols LK, O&apos;Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68: 227-232, 1991.","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mitry E, Baudin E, Ducreux M, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 81: 1351-1355, 1999.","DOI":"10.1038\/sj.bjc.6690325"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Iwasa S, Morizane C, Okusaka T, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol 40: 313-318, 2010.","DOI":"10.1093\/jjco\/hyp173"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamaguchi T, Machida N, Morizane C, et al. Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Cancer Sci 105: 1176-1181, 2014.","DOI":"10.1111\/cas.12473"},{"key":"17","unstructured":"17. Chin K, Baba S, Hosaka H, et al. Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol 38: 426-431, 2008."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Okita NT, Kato K, Takahari D, et al. Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma. Gastric Cancer 14: 161-165, 2011.","DOI":"10.1007\/s10120-011-0025-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kulke MH, Wu B, Ryan DP, et al. A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci 51: 1033-1038, 2006.","DOI":"10.1007\/s10620-006-8001-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mani MA, Shroff RT, Jacobs C, et al. A phase II study of irinotecan and cisplatin for metastatic or unresectable high grade neuroendocrine carcinoma [abstract]. J Clin Oncol 26: 15550, 2008.","DOI":"10.1200\/jco.2008.26.15_suppl.15550"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lu ZH, Li J, Lu M, et al. Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas. Med Oncol 30: 664, 2013.","DOI":"10.1007\/s12032-013-0664-y"},{"key":"22","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4081\/rt.2013.e39","volume":"5","author":"R Ramella Munhoz","year":"2013","unstructured":"22. Ramella Munhoz R, de Mendon\u00e7a Rego JF, de Celis Ferrari AR, et al. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare Tumors 5: e39, 2013.","journal-title":"Rare Tumors","ISSN":"http:\/\/id.crossref.org\/issn\/2036-3605","issn-type":"print"},{"key":"23","unstructured":"23. Midorikawa R, Ohchi T, Shigaki T, et al. Endocrine cell carcinoma of the esophagus without recurrence for more than 7 years after chemoradiotherapy. Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastro-enterol) 116: 71-79, 2019 (in Japanese, Abstract in English)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4584-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T03:43:32Z","timestamp":1602906212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4584-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":23,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4584-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}